-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment options for acute myelocytic leukemia
Michael S Mathisen, Hagop M Kantarjian, Jorge Cortes, Farhad Ravandi & Elias J Jabbour
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Acknowledgements: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation
-
Denosumab open-label extension trial shows positive results for osteoporosis treatment
News and Views: Clinical Investigation